UN puts AI Titans on the hook for billions of dollars of biopiracy payments
By Jim Thomas,
Scan the Horizon
| 11. 19. 2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. The decision, while seemingly about paying for genetic data, sets a significant wider precedent for how AI firms can be held accountable for stealing training data without consent or recompense.
Here is the context: After years of stand-offs and diplomatic wrangling, the United Nation’s Convention on Biological Diversity (UN CBD) this month adopted a landmark decision on something called “DSI”. DSI stands for Digital Sequence Information. It refers to digital versions of biological ‘codes’ such as DNA, RNA or the amino acids in proteins. These biological “codes” are routinely collected, stored and processed in digital form and have become the raw commodity powering the global$1.5 trillion dollar biotech industry. Originally sequenced from plants, animals, bacteria and viruses extracted from territories (plus human medical samples) the sheer volume of ‘DSI’ now stacking up in servers and databases rivals much of...
Related Articles
By Jenny Lange, BioNews | 12.01.2025
A UK toddler with a rare genetic condition was the first person to receive a new gene therapy that appears to halt disease progression.
Oliver, now three years old, has Hunter syndrome, an inherited genetic disorder that leads to physical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Pam Belluck and Carl Zimmer, The New York Times | 11.19.2025
Gene-editing therapies offer great hope for treating rare diseases, but they face big hurdles: the tremendous time and resources involved in devising a treatment that might only apply to a small number of patients.
A study published on Wednesday...
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...